Hubungan Antara Konsumsi Tablet Tambah Darah Dengan Kejadian Anemia Pada Ibu Hamil

Abstract

One of the causes of maternal mortality during pregnancy is anemia. As of June 2023, the prevalence of anemia among pregnant women at Margomulyo Health Center was 3.97%. Taking iron supplements is a form of action to overcome and prevent anemia during pregnancy. Iron supplements play a crucial role in improving hemoglobin levels. This study aims to determine the relationship between iron supplement consumption and the incidence of anemia in pregnant women. A quantitative study with a cross-sectional design was used. Respondents were determined using purposive sampling technique, specifically pregnant women in their second and third trimesters without complications, and the sample size was calculated using the Slovin formula, resulting in 80 respondents. The study was conducted in July 2023. Data were collected through interviews, checklists, and laboratory examinations using the Sahli Hb meter. The data sources were primary data from checklists and secondary data from records at Margomulyo Health Center, Muara Sugihan District. The instrument used was adopted from previous researchers and had been tested for reliability and validity. Data analysis was performed using the Chi-square test. The statistical test results showed a p-value of 0.002 < α 0.05, indicating a statistically significant relationship between iron supplement consumption and anemia incidence in pregnant women. Pregnant women who regularly took iron supplements were 0.126 times less likely to suffer from anemia compared to those who did not. Nurses can analyze risk factors that influence anemia incidence in pregnant women who take iron supplements, such as nutritional status, dietary intake, and medical history